However, this is understandable, as the majority of EGFR mutations and ALK-positivity cases were found in adenocarcinomas, with an extremely low mutation rate in squamous cell carcinoma (< 5%) [43]. The gene discussed is EGFR; the disease is adenocarcinoma.